1 Start 2 Complete InstructionsPlease complete the Module 9: Cardiometabolic Considerations in Racial and Ethnic Minorities Follow-up Survey and tell us what you learned from this module. Your response is important, and will be used to demonstrate the value of this educational program and to guide development of future CME activities. Thank you for your participation. Please provide your email so we can contact you with promotional information including drawings and prizes for completing this survey. This field is optional. Which of these describes health disparities in cardiology? * Adverse cardiovascular outcomes and/or health status that is attributable to systemic, avoidable, and unjust societal factors Systemic, avoidable, and often unjust societal factors, structural practices, and racism that creates barriers A human right that allows everyone to achieve best attainable cardiovascular health and outcomes Social, economic, educational, and environmental conditions that influence cardiovascular health Which of the following is the largest mediator of increased incidence of hypertension and stroke in blacks vs whites? * Southern diet Consuming a lot of sweets Convenience food Unsure Which of the following drugs has been shown to increase survival in black patients with advanced heart failure? * Empagliflozin Dapagliflozin Isosorbide dinitrate + hydralazine Compared to Whites or Hispanics/Latinos, Blacks have: * Higher LDL-C levels Increased and high TG levels Lower levels of HDL-C Higher levels of HDL-C and lower levels of TG How many patient encounters have you had in the last 90 days? * <200 200 400 600 800 1000 1200 >1200 As a result of this educational activity, did you make any changes to your clinical practice? * Yes No What specific changes did you make to your practice as a result of information received in this activity? (Select all that apply) * Review, address, or discuss social determinants of health as an important factor that can influence therapy and outcomes in cardiometabolic patients from underserved communities Discuss attainable lifestyle modifications as the pillar of cardiometabolic risk reduction in patients from racial and ethnic minorities Identify unique cardiometabolic risk factors in patient from racial and ethnic minorities Take into account racial and ethnic differences when individualizing therapy for hypertension, type 2 diabetes, cholesterol, and heart failure. What additional improvements have you made in your clinical practice after participating in this activity? * What barriers are currently preventing you from making these changes? (select all that apply) * Formulary restrictions Insurance/financial issues Time constraints Lack of interprofessional team support System constraints Treatment related adverse events Patient adherence/compliance None Were the changes that you made in clinical practice beneficial to patient care?* * Yes No Has this course improved the comprehensive treatment of your patients with cardiometabolic disease or cardiometabolic risk? * Yes No Please explain your above answer. * Leave this field blank
